annual SGA:
$476.44M+$46.76M(+10.88%)Summary
- As of today (June 22, 2025), AMRX annual SGA is $476.44 million, with the most recent change of +$46.76 million (+10.88%) on December 31, 2024.
- During the last 3 years, AMRX annual SGA has risen by +$110.93 million (+30.35%).
- AMRX annual SGA is now at all-time high.
Performance
AMRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$118.29M-$10.40M(-8.08%)Summary
- As of today (June 22, 2025), AMRX quarterly SGA is $118.29 million, with the most recent change of -$10.40 million (-8.08%) on March 31, 2025.
- Over the past year, AMRX quarterly SGA has increased by +$5.69 million (+5.06%).
- AMRX quarterly SGA is now -8.08% below its all-time high of $128.69 million, reached on December 31, 2024.
Performance
AMRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$2.35B-$13.05M(-0.56%)Summary
- As of today (June 22, 2025), AMRX TTM SGA is -$2.35 billion, with the most recent change of -$13.05 million (-0.56%) on March 31, 2025.
- Over the past year, AMRX TTM SGA has dropped by -$2.79 billion (-634.73%).
Performance
AMRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AMRX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | +5.1% | -634.7% |
| 3 y3 years | +30.4% | +19.9% | -730.3% |
| 5 y5 years | +64.5% | +51.7% | -931.3% |
AMRX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.4% | -8.1% | +19.9% | -116.0% | at low |
| 5 y | 5-year | at high | +64.5% | -8.1% | +51.7% | -120.5% | at low |
| alltime | all time | at high | +336.9% | -8.1% | +370.9% | <-9999.0% | at low |
AMRX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $118.29M(-8.1%) | $482.13M(+1.2%) |
| Dec 2024 | $476.44M(+10.9%) | $128.69M(+8.4%) | $476.44M(+4.3%) |
| Sep 2024 | - | $118.69M(+1.9%) | $456.75M(+1.3%) |
| Jun 2024 | - | $116.46M(+3.4%) | $451.07M(+2.5%) |
| Mar 2024 | - | $112.59M(+3.3%) | $440.17M(+2.4%) |
| Dec 2023 | $429.68M(+7.5%) | $109.00M(-3.5%) | $429.68M(+1.6%) |
| Sep 2023 | - | $113.01M(+7.0%) | $422.83M(+3.2%) |
| Jun 2023 | - | $105.57M(+3.4%) | $409.89M(+1.7%) |
| Mar 2023 | - | $102.10M(-0.1%) | $403.13M(+0.9%) |
| Dec 2022 | $399.70M(+9.4%) | $102.16M(+2.1%) | $399.70M(+1.2%) |
| Sep 2022 | - | $100.07M(+1.3%) | $394.77M(+2.2%) |
| Jun 2022 | - | $98.81M(+0.1%) | $386.09M(+3.4%) |
| Mar 2022 | - | $98.67M(+1.5%) | $373.44M(+2.2%) |
| Dec 2021 | $365.50M | $97.22M(+6.4%) | $365.50M(+3.6%) |
| Sep 2021 | - | $91.40M(+6.1%) | $352.97M(+2.4%) |
| Jun 2021 | - | $86.16M(-5.0%) | $344.69M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $90.73M(+7.1%) | $339.48M(+3.9%) |
| Dec 2020 | $326.73M(+12.8%) | $84.69M(+1.9%) | $326.73M(+3.4%) |
| Sep 2020 | - | $83.12M(+2.7%) | $316.12M(+6.5%) |
| Jun 2020 | - | $80.94M(+3.8%) | $296.80M(+4.8%) |
| Mar 2020 | - | $77.98M(+5.3%) | $283.14M(-2.2%) |
| Dec 2019 | $289.60M(+27.1%) | $74.08M(+16.1%) | $289.60M(+1.0%) |
| Sep 2019 | - | $63.80M(-5.2%) | $286.75M(-3.9%) |
| Jun 2019 | - | $67.28M(-20.3%) | $298.44M(+3.9%) |
| Mar 2019 | - | $84.44M(+18.5%) | $287.16M(+26.0%) |
| Dec 2018 | $227.85M(+108.9%) | $71.24M(-5.6%) | $227.85M(+24.1%) |
| Sep 2018 | - | $75.49M(+34.8%) | $183.58M(+35.5%) |
| Jun 2018 | - | $56.00M(+122.9%) | $135.53M(+27.3%) |
| Mar 2018 | - | $25.12M(-6.8%) | $106.47M(+30.9%) |
| Dec 2017 | $109.05M(-8.2%) | $26.97M(-1.7%) | $81.34M(+49.6%) |
| Sep 2017 | - | $27.44M(+1.9%) | $54.38M(+101.9%) |
| Jun 2017 | - | $26.94M | $26.94M |
| Dec 2016 | $118.76M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual SGA year-on-year change?
- What is Amneal Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly SGA year-on-year change?
- What is Amneal Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM SGA year-on-year change?
What is Amneal Pharmaceuticals annual SGA?
The current annual SGA of AMRX is $476.44M
What is the all time high annual SGA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual SGA is $476.44M
What is Amneal Pharmaceuticals annual SGA year-on-year change?
Over the past year, AMRX annual SGA has changed by +$46.76M (+10.88%)
What is Amneal Pharmaceuticals quarterly SGA?
The current quarterly SGA of AMRX is $118.29M
What is the all time high quarterly SGA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly SGA is $128.69M
What is Amneal Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, AMRX quarterly SGA has changed by +$5.69M (+5.06%)
What is Amneal Pharmaceuticals TTM SGA?
The current TTM SGA of AMRX is -$2.35B
What is the all time high TTM SGA for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM SGA is $0.00
What is Amneal Pharmaceuticals TTM SGA year-on-year change?
Over the past year, AMRX TTM SGA has changed by -$2.79B (-634.73%)